<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85041594922</prism:url><dc:identifier>SCOPUS_ID:85041594922</dc:identifier><eid>2-s2.0-85041594922</eid><pubmed-id>29391566</pubmed-id><prism:doi>10.1038/s41598-018-20632-6</prism:doi><article-number>2178</article-number><dc:title>Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><citedby-count>6</citedby-count><prism:publicationName>Scientific Reports</prism:publicationName><dc:publisher>
                        Nature Publishing Group
                        
                            Houndmills
                            Basingstoke, Hampshire
                            RG21 6XS
                        
                    </dc:publisher><source-id>21100200805</source-id><prism:issn>20452322</prism:issn><prism:volume>8</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2018-12-01</prism:coverDate><openaccess>1</openaccess><openaccessFlag>true</openaccessFlag><dc:creator><author seq="1" auid="56830057500"><ce:initials>R.L.</ce:initials><ce:indexed-name>Ball R.L.</ce:indexed-name><ce:surname>Ball</ce:surname><ce:given-name>Rebecca L.</ce:given-name><preferred-name><ce:initials>R.L.</ce:initials><ce:indexed-name>Ball R.</ce:indexed-name><ce:surname>Ball</ce:surname><ce:given-name>Rebecca L.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/56830057500</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng">
                        <publishercopyright>Â© 2018 The Author(s).</publishercopyright>
                        <ce:para>Oral delivery, a patient-friendly means of drug delivery, is preferred for local administration of intestinal therapeutics. Lipidoid nanoparticles, which have been previously shown to deliver siRNA to intestinal epithelial cells, have potential to treat intestinal disease. It is unknown, however, whether the oral delivery of these particles is possible. To better understand the fate of lipid nanoparticles in the gastrointestinal (GI) tract, we studied delivery under deconstructed stomach and intestinal conditions in vitro. Lipid nanoparticles remained potent and stable following exposure to solutions with pH values as low as 1.2. Efficacy decreased following exposure to "fed", but not "fasting" concentrations of pepsin and bile salts. The presence of mucin on Caco-2 cells also reduced potency, although this effect was mitigated slightly by increasing the percentage of PEG in the lipid nanoparticle. Mouse biodistribution studies indicated that siRNA-loaded nanoparticles were retained in the GI tract for at least 8 hours. Although gene silencing was not initially observed following oral LNP delivery, confocal microscopy confirmed that nanoparticles entered the epithelial cells of the mouse small intestine and colon. Together, these data suggest that orally-delivered LNPs should be protected in the stomach and upper intestine to promote siRNA delivery to intestinal epithelial cells.</ce:para>
                    </abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85041594922" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85041594922&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85041594922&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"><affilname>Carnegie Mellon University</affilname><affiliation-city>Pittsburgh</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><authors><author seq="1" auid="56830057500"><ce:initials>R.L.</ce:initials><ce:indexed-name>Ball R.L.</ce:indexed-name><ce:surname>Ball</ce:surname><ce:given-name>Rebecca L.</ce:given-name><preferred-name><ce:initials>R.L.</ce:initials><ce:indexed-name>Ball R.</ce:indexed-name><ce:surname>Ball</ce:surname><ce:given-name>Rebecca L.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/56830057500</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author><author seq="2" auid="57193015226"><ce:initials>P.</ce:initials><ce:indexed-name>Bajaj P.</ce:indexed-name><ce:surname>Bajaj</ce:surname><ce:given-name>Palak</ce:given-name><preferred-name><ce:initials>P.</ce:initials><ce:indexed-name>Bajaj P.</ce:indexed-name><ce:surname>Bajaj</ce:surname><ce:given-name>Palak</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57193015226</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author><author seq="3" auid="35609935600"><ce:initials>K.A.</ce:initials><ce:indexed-name>Whitehead K.A.</ce:indexed-name><ce:surname>Whitehead</ce:surname><ce:given-name>Kathryn A.</ce:given-name><preferred-name><ce:initials>K.A.</ce:initials><ce:indexed-name>Whitehead K.</ce:indexed-name><ce:surname>Whitehead</ce:surname><ce:given-name>Kathryn A.</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/35609935600</author-url><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/><affiliation id="60027950" href="https://api.elsevier.com/content/affiliation/affiliation_id/60027950"/></author></authors></abstracts-retrieval-response>